Biodesix, Inc. (BDSX)
Total Valuation
Biodesix has a market cap or net worth of $183.59 million. The enterprise value is $191.92 million.
Market Cap | 183.59M |
Enterprise Value | 191.92M |
Important Dates
The next earnings date is Monday, March 13, 2023, after market close.
Estimated Earnings Date | Mar 13, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Biodesix has 76.50 million shares outstanding. The number of shares has increased by 44.19% in one year.
Shares Outstanding | 76.50M |
Shares Change (YoY) | +44.19% |
Shares Change (QoQ) | +3.08% |
Owned by Insiders (%) | 70.91% |
Owned by Institutions (%) | 6.35% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.12 |
Forward PS | 3.43 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.36 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65
Current Ratio | 0.65 |
Quick Ratio | 0.52 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -723.60% and return on invested capital (ROIC) is -798.80%.
Return on Equity (ROE) | -723.60% |
Return on Assets (ROA) | -84.60% |
Return on Capital (ROIC) | -798.80% |
Revenue Per Employee | $164,353 |
Profits Per Employee | -$267,849 |
Employee Count | 218 |
Asset Turnover | 0.52 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.84% in the last 52 weeks. The beta is 1.47, so Biodesix's price volatility has been higher than the market average.
Beta (1Y) | 1.47 |
52-Week Price Change | -37.84% |
50-Day Moving Average | 1.90 |
200-Day Moving Average | 1.70 |
Average Volume (30 Days) | 190,095 |
Short Selling Information
The latest short interest is 237,568, so 0.31% of the outstanding shares have been sold short.
Short Interest | 237,568 |
Short Previous Month | 280,937 |
Short % of Shares Out | 0.31% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, Biodesix had revenue of $35.83 million and -$58.39 million in losses. Loss per share was -$1.73.
Revenue | 35.83M |
Gross Profit | 22.49M |
Operating Income | -48.38M |
Pretax Income | -58.39M |
Net Income | -58.39M |
EBITDA | -46.32M |
EBIT | -51.37M |
Loss Per Share | -$1.73 |
Balance Sheet
The company has $15.18 million in cash and $23.51 million in debt, giving a net cash position of -$8.33 million or -$0.11 per share.
Cash & Cash Equivalents | 15.18M |
Total Debt | 23.51M |
Net Cash | -8.33M |
Net Cash Per Share | -$0.11 |
Equity / Book Value | -2.90M |
Book Value Per Share | -0.04 |
Working Capital | -13.30M |
Cash Flow
In the last 12 months, operating cash flow was -$43.22 million and capital expenditures -$2.19 million, giving a free cash flow of -$45.41 million.
Operating Cash Flow | -43.22M |
Capital Expenditures | -2.19M |
Free Cash Flow | -45.41M |
FCF Per Share | -$1.12 |
Margins
Gross margin is 62.76%, with operating and profit margins of -135.02% and -162.97%.
Gross Margin | 62.76% |
Operating Margin | -135.02% |
Pretax Margin | -162.97% |
Profit Margin | -162.97% |
EBITDA Margin | -129.28% |
EBIT Margin | -143.38% |
FCF Margin | -126.74% |
Dividends & Yields
Biodesix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -31.81% |
FCF Yield | -24.73% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -44.19% |
Shareholder Yield | -44.19% |
Analyst Forecast
The average price target for Biodesix is $5.10, which is 112.50% higher than the current price. The consensus rating is "Buy".
Price Target | $5.10 |
Price Target Difference | 112.50% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |